Skip to main content
OpenTrials

Clinical trial condition

Primary Immune Thrombocytopenia (ITP)

Explore clinical trials studying Primary Immune Thrombocytopenia (ITP). Study availability and eligibility vary by location and protocol.

21 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Primary Immune Thrombocytopenia (ITP) trial results

Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View Trial Details
Recruiting

An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

NCT07233213

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Hacettepe University Faculty of Medicine Ankara, Altındağ, Turkey (Türkiye)
  • İnönü University Turgut Ozal Medical Center Training and Research Hospital Malatya, Battalgazi, Turkey (Türkiye)
  • İstanbul University, Istanbul Faculty of Medicine Istanbul, Fatih, Turkey (Türkiye)
  • Erciyes University Hematology Hospital Kayseri, Melikgazi, Turkey (Türkiye)
View Trial Details
Recruiting

Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)

NCT06880081

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • Jining First People's Hospital Jining, Shandong, China
  • Hematology Hospital of Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

NCT06929299

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • North China University of Science and Technology Affiliated Hospital Tangshan, Hebei, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Recruiting

RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia

NCT06919341

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Complexo Hospitalario Universitario A Coruña A Coruña, Spain
  • Hospital Universitario Son Espases Palma, Balearic Islands, Spain
  • Hospital Del Mar Barcelona, Spain
  • Hospital Vall d'Hebron ( Barcelona, Spain
View all 36 locations
View Trial Details

Related conditions